![]() |
What is SMA? Spinal Muscular Atrophy (SMA) is a debilitating, genetic neuromuscular disease and is the leading genetic killer of children under the age of two. SMA destroys the nerves controlling voluntary muscle movement, which affects crawling, walking, head and neck control, and even swallowing. One in every 6,000 babies is born with the disease and one-half of children diagnosed with the most severe form-type 1- will not reach their second birthday. SMA can strike anyone of any race or gender. One in every 40 people (7.5 million Americans) carries the gene that causes SMA. There is NO CURE or proven treatment! |
![]() |
What causes SMA? In order for a child to be affected by SMA, both parents must be carriers of the abnormal gene and both must pass this gene on to their child. Although both parents are carriers the likelihood of a child inheriting the disorder is 25%, or 1 in 4. An individual with SMA has a missing or mutated gene (SMN1, or survival motor neuron 1) that produces a protein in the body called Survival Motor Neuron (SMN) protein. This protein deficiency has its most severe affect on motor neurons. Motor neurons are nerve cells in the spinal cord which send out nerve fibers to muscles throughout the body. Since SMN protein is critical to the survival and health of motor neurons, without this protein nerve cells may atrophy, shrink and eventually die, resulting in muscle weakness. There are four types of SMA, SMA Type I, II, III, IV. The determination of the type of SMA is based upon the physical milestones achieved. It is important to note that the course of the disease may be different for each child. |
![]() |
What SMA reserach is being conducted? The ultimate goal at Families of SMA is to accelerate the discovery of an effective treatment and cure for SMA. 1. basic research to unravel the biology of SMA, 2. pre-clinical drug discovery to develop SMA drugs, and 3. human clinical trial initiatives to test these new drugs. We are also making substantial investments in promising alternative therapies, such as stem cell therapy to diversify and so improve our chances for success. All
three of these research areas are equally critical and are
interdependent. Basic research in SMA biology tells us what causes
SMA. Understanding what causes SMA reveals new and more effective ways
of making SMA drugs. Pre-clinical drug discovery programs then convert
basic research ideas into new, better, and more directed SMA drug
candidates. Establishing clinical trial infrastructure provides the
means to test these new drug candidates in humans. Therefore, continued investment in all these research areas is essential to finding an effective SMA treatment and ultimately a cure. |
![]() |
How can you help? You can help by donating to Families of Spinal Muscular Atrophy. The Alabama Chapter of Families of Spinal Muscular Atrophy is a volunteer based chapter dedicated to providing support to families in Alabama affected by SMA, to raising funds to support research for a cure, and to promoting awareness about SMA to the community and medical professionals. Families of SMA is a 501 (c)(3) tax-exempt organization. Nationally, $25 million has been raised for research to find a cure. |